Inclusion completed

Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma

Cancer type: Myeloma

Phase: I

Principal Investigator: Gimsing Peter

Country: DK

Keywords: Denmark, Rigshospitalet, Anti-CD-38, monoclonal antibody, multiple myeloma

Status: Inclusion completed

Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT01615029